Generic Single-Dose Flu Antiviral Gets FDA’s Blessing
The FDA this week approved the first generic version of baloxavir marboxil (Xofluza) as a single-dose option to treat or prevent influenza in adults and children 5 years and up.…
FDA Approves Oral Antiviral to Prevent COVID-19 After Exposure
The FDA approved the oral antiviral agent ensitrelvir (Xocova) to help prevent COVID-19 in people ages 12 years or older who were exposed to the SARS-CoV-2 virus, drugmaker Shionogi announced.…
